Skip to content

AMN Healthcare AMN Restricted Marketable Securities

Restricted Marketable Securities at other companies

Credit Acceptance logo
Credit AcceptanceCACC
$109.4M+0.4%
Orrstown Financial Services logo
Orrstown Financial ServicesORRF
$23.98M+21.8%
Atlantic Union Bankshares logo
Atlantic Union BanksharesAUB
$177.51M+77.0%
Fulton Financial logo
Fulton FinancialFULT
$119.95M-11.9%
ESQ
Esquire Financial Holdings, Inc.ESQ
$3.17M+4.6%
HBT
HBT Financial, Inc.HBT
$6M+18.0%

Other financials

Income statement

See full
Revenue$1.4B+99.9%
Gross profit$368.8M+86.2%
Operating income$117.2M+837%
Net income$62.2M+5,793%
EPS (diluted)$1.59+5,400%

Balance sheet

See full
Cash & equivalents$595.0M+528%
Total debt$776.9M-12.4%
Total equity$712.8M-0.3%
Total assets$2.6B+8.7%

Cash flow

See full
Operating cash flow$562.5M+507%
CapEx$7.2M-27.4%
Free cash flow$555.2M+571%

Valuation

See full
Market cap$1.23B+47.0%
Enterprise value$1.41B-13.3%
P/S0.4×+0.1×

Profitability

See full
Gross margin27.6%-2.5pp
Operating margin-9.8%-14.2pp
Net margin-0.9%-0.4pp
FCF margin20.7%+11.6pp

Returns & leverage

See full
Return on equity-4.5%-2.0pp
Debt / equity1.1×-0.2×
Current ratio1.1×0.0×

Where this comes from

Reported directly by AMN Healthcare in its filing.

Tagged under the XBRL concept us-gaap:RestrictedInvestments.

The official record: AMN Healthcare’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about AMN Healthcare's restricted marketable securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AMN Healthcare's restricted marketable securities?
AMN Healthcare (AMN) reported restricted marketable securities of $34.1M in Q1 2026.
How has AMN Healthcare's restricted marketable securities changed year-over-year?
AMN Healthcare's restricted marketable securities increased by 50.0% year-over-year, from $22.73M to $34.1M.
What is the long-term trend for AMN Healthcare's restricted marketable securities?
Over 5 years (2020 to 2025), AMN Healthcare's restricted marketable securities has grown at a 6.2% compound annual growth rate (CAGR), from $25.2M to $34.04M.